TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Biotech Stock Mailbag: Generex Bio

  • By Adam Feuerstein
  • Jun 24, 2011 7:00 AM EDT
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Biotech Stock Mailbag: NuPathe

  • By Adam Feuerstein
  • Jun 17, 2011 6:53 AM EDT
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Mailbag: BIO CEO Wrap

  • By Adam Feuerstein
  • Feb 18, 2011 7:00 AM EST
STOCKS

New Cancer Vaccine the Next Dendreon?

  • By Adam Feuerstein
  • May 3, 2010 1:03 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.